BioMarin Pharmaceutical, Inc. United States of America (USA)

Research

Date range: 1 June 2022 - 31 May 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for BioMarin Pharmaceutical, Inc. published between 1 June 2022 - 31 May 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for BioMarin Pharmaceutical, Inc.
Count Share
5 1.35

Outputs by subject (Share)

Outputs by subject
Subject Count Share
4 1.07
3 0.30

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022*
0.17 1.38 0.94 1.02 2.61

Compare BioMarin Pharmaceutical, Inc. with other institutions

*Note: 2022 data contains Share for article affiliations from newly added health-science journals.

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Get started

Collaboration

Date range: 1 June 2022 - 31 May 2023

International vs. domestic collaboration by Share

  • 32.87% Domestic (16 institutions)
  • 67.13% International (74 institutions)

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with BioMarin Pharmaceutical, Inc. by Share*

  1. BioMarin Pharmaceutical, Inc. and Harvard University (0.69)
    BioMarin Pharmaceutical, Inc.
    Harvard University0.67
  2. BioMarin Pharmaceutical, Inc. and Broad Institute of MIT and Harvard (0.46)
    BioMarin Pharmaceutical, Inc.
    Broad Institute of MIT and Harvard0.44
  3. BioMarin Pharmaceutical, Inc. and University of California, San Francisco (UCSF) (0.42)
    BioMarin Pharmaceutical, Inc.0.33
    University of California, San Francisco (UCSF)0.09
  4. BioMarin Pharmaceutical, Inc. and University of Minnesota (UMN) (0.42)
    BioMarin Pharmaceutical, Inc.0.33
    University of Minnesota (UMN)0.09
  5. BioMarin Pharmaceutical, Inc. and Hemophilia Foundation of Southern California (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    Hemophilia Foundation of Southern California
  6. BioMarin Pharmaceutical, Inc. and The Ohio State University (OSU) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    The Ohio State University (OSU)
  7. BioMarin Pharmaceutical, Inc. and The University of North Carolina at Chapel Hill (UNC) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    The University of North Carolina at Chapel Hill (UNC)
  8. BioMarin Pharmaceutical, Inc. and University of California, San Diego (UC San Diego) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    University of California, San Diego (UC San Diego)
  9. BioMarin Pharmaceutical, Inc. and University of Colorado Anschutz Medical Campus (CU Anschutz) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    University of Colorado Anschutz Medical Campus (CU Anschutz)
  10. BioMarin Pharmaceutical, Inc. and University of Michigan (U-M) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    University of Michigan (U-M)

Top 10 international collaborators with BioMarin Pharmaceutical, Inc. by Share*

  1. BioMarin Pharmaceutical, Inc. and University of Cambridge (0.38)
    BioMarin Pharmaceutical, Inc.
    University of Cambridge0.37
  2. BioMarin Pharmaceutical, Inc. and Imperial College London (ICL) (0.35)
    BioMarin Pharmaceutical, Inc.0.29
    Imperial College London (ICL)
  3. BioMarin Pharmaceutical, Inc. and Cambridge University Hospitals NHS Foundation Trust (0.33)
    BioMarin Pharmaceutical, Inc.0.29
    Cambridge University Hospitals NHS Foundation Trust
  4. BioMarin Pharmaceutical, Inc. and University of Oxford (0.32)
    BioMarin Pharmaceutical, Inc.0.29
    University of Oxford
  5. BioMarin Pharmaceutical, Inc. and Guy's and St Thomas' NHS Foundation Trust (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    Guy's and St Thomas' NHS Foundation Trust
  6. BioMarin Pharmaceutical, Inc. and State University of Campinas (UNICAMP) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    State University of Campinas (UNICAMP)
  7. BioMarin Pharmaceutical, Inc. and University of Bonn (Uni Bonn) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    University of Bonn (Uni Bonn)
  8. BioMarin Pharmaceutical, Inc. and NIHR Oxford Biomedical Research Centre (OxBRC) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    NIHR Oxford Biomedical Research Centre (OxBRC)
  9. BioMarin Pharmaceutical, Inc. and National Taiwan University (NTU) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    National Taiwan University (NTU)
  10. BioMarin Pharmaceutical, Inc. and Centre de Recherche en Cardiovasculaire et Nutrition (C2VN) (0.31)
    BioMarin Pharmaceutical, Inc.0.28
    Centre de Recherche en Cardiovasculaire et Nutrition (C2VN)

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.

Nature Careers

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

Relationships

BioMarin Pharmaceutical, Inc.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.